7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate
Open Biology · 2023-05 · 13 (5)
DOI: 10.1098/rsob.220370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Biology, online erschienen am 17.05.2023. Verfasst von M T Herrero und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Neuroscience (NiCE), Institute for Aging Research, School of Medicine, Campus Mare Nostrum, The European University for Wel…. Hauptthemen laut MEDLINE: Parkinsonian Disorders, Dyskinesia, Drug-Induced, Parkinson Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Spanish Ministry of Science, Innovation and Universities, Universitary Hospital Morales Meseguer, Fundación Séneca.
Abstract (Originalsprache)
Nitric oxide (NO) plays a pivotal role in integrating dopamine transmission in the basal ganglia and has been implicated in the pathogenesis of Parkinson disease (PD). The objective of this study was to ascertain whether the NO synthase inhibitor, 7-nitroindazole (7-NI), is able to reduce L-DOPA-induced dyskinesias (LIDs) in a non-human primate model of PD chronically intoxicated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Six Parkinsonian macaques were treated daily with L-DOPA for 3–4 months until they developed LIDs. Three animals were then co-treated with a single dose of 7-NI administered 45 min before each L-DOPA treatment. Dyskinetic MPTP-treated monkeys showed a significant decrease in LIDs compared with their scores without 7-NI treatment ( p < 0.05). The anti-Parkinsonian effect of L-DOPA was similar in all three monkeys with and without 7-NI co-treatment. This improvement was significant with respect to the intensity and duration of LIDs while the beneficial effect of L-DOPA treatment was maintained and could represent a promising therapy to improve the quality of life of PD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Experimental Neuroscience (NiCE), Institute for Aging Research, School of Medicine, Campus Mare Nostrum, The European University for Well-Being, EUniWell, University of Murcia, Spain.
- Biomedical Research Institute of Murcia (IMIB-Pascual Parrilla), Campus of Health Sciences, University of Murcia, 30120 Murcia, Spain.
- Department of Pharmacology, School of Medicine, University of Murcia, Campus Mare Nostrum, 30100 Murcia, Spain.
- Department of Basic and Oral Biology, Faculty of Odontology of Ribeirão Preto (FORP-USP) and Center for Research Support on Applied Neuroscience (NAPNA-USP), University of São Paulo, Ribeirão Preto, SP 14040-904, Brazil.
ORCID-Profile: M T Herrero, J E Yuste
Förderung
- Spanish Ministry of Science, Innovation and Universities
- Universitary Hospital Morales Meseguer
- Fundación Séneca
- Ministerio de Ciencia e Innovación
- Universidad de Murcia
Zitieren
APA
Herrero, M. T., Yuste, J. E., Cuenca-Bermejo, L., Almela, P., Arenas-Betancur, L., De Pablos, V., Gonzalez-Cuello, A., Del Bel, E., Navarro-Zaragoza, J., & Fernández-Villalba, E. (2023). 7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate. Open Biology, 13(5). https://doi.org/10.1098/rsob.220370
Vancouver
Herrero MT, Yuste JE, Cuenca-Bermejo L, Almela P, Arenas-Betancur L, De Pablos V, et al. 7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate. Open Biology. 2023;13(5). doi:10.1098/rsob.220370
BibTeX
@article{Herrero2023,
author = {Herrero, M T and Yuste, J E and Cuenca-Bermejo, L and Almela, P and Arenas-Betancur, L and De Pablos, V and Gonzalez-Cuello, A and Del Bel, E and Navarro-Zaragoza, J and Fernández-Villalba, E},
title = {7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate},
journal = {Open Biology},
year = {2023},
volume = {13},
number = {5},
doi = {10.1098/rsob.220370}
}
EUVIMED